SEP 14, 2016 11:32 AM PDT

Aspirin's Effects on Cardiovascular Disease and Colon Cancer

WRITTEN BY: Jennifer Ellis
‘An aspirin a day keeps the doctor away’
 
There have been conflicting views over the effects of aspirin over its more than 100 year reign as a diverse cure all to pain relief and preventative of heart disease and some cancers. Its mechanism for pain relief has long been proven by its ability to block the COX-1 enzyme, involved in inflammation and blood clotting. While this makes sense for pain relief, how does this associate with cardiovascular disease and cancer?
Mechanism of Aspirin blocking COX-1 (Libretexts/UCDavis)
A new approach from a team of scientists at Duke Health, led by Deepak Voora, M.D., assistant professor in Duke’s Center for Applied Genomics & Precision Medicine, can evaluate specific drug actions using genomic data, providing the team with an explanation of mechanisms of drug activity in the body. The team created an aspirin response signature (ARS) that allowed them to examine gene activity patterns in blood upon aspirin exposure. The ARS was developed using blood gene expression profiling methods before and after aspirin exposure in a set of healthy volunteers and validating the signature in a separate set of healthy and diseased patients.
 
The ARS consists of a network of 62 co-expressed transcripts associated with aspirin’s effects on platelet function and myocardial infarction. This gene network contained one commonality: regulation by RUNX1, a key regulator of genes controlling platelet and megakaryocyte function. The team discovered that aspirin can regulate RUNX1 gene expression, affecting associated platelet proteins. Up regulation of RUNX1 in blood is associated with decreased risk of death and heart attack in cardiovascular disease patients. RUNX1 is also a tumor suppressor correlated with increased survival rates in colon cancer patients.
Platelets are derived from megakaryocytes in the bone marrow and aid in clotting. (Public Domain)
Not only did the approach taken in this study shed additional light on aspirin’s specific mechanisms, it also provides a new way of thinking about how to look at drug activity using genomic profiling.

“This approach to comprehensively evaluate the actions of a drug using genomic data -- as we have done here with aspirin -- is a paradigm shift that could change how drugs are developed and positioned for clinical use, said co-author Geoffrey Ginsburg, M.D., director of the Center for Applied Genomics & Precision Medicine.

It turns out that aspirin’s diverse effects on several diseases are due to its ability to regulate gene expression of a common regulator. So, depending on your health, an aspirin a day might indeed keep the doctor away.

Sources: Duke Medicine, NCBI, EBioMedicine
 
About the Author
MS
I love all things science and am passionate about bringing science to the public through writing. With an M.S. in Genetics and experience in cancer research, marketing and technical writing, it is a pleasure to share the latest trends and findings in science on LabRoots.
You May Also Like
MAR 10, 2022
Cardiology
Blood Pressure Rose Due to the COVID-19 Pandemic
MAR 10, 2022
Blood Pressure Rose Due to the COVID-19 Pandemic
COVID-19 disrupted the lives of millions of people, and two new studies have shown that it also increased blood pressure ...
MAR 17, 2022
Cardiology
Coffee May Lower Risk of Heart Failure
MAR 17, 2022
Coffee May Lower Risk of Heart Failure
A new study has linked caffeinated coffee to a lower risk of heart failure.
APR 14, 2022
Cardiology
Sleep and Heart Health
APR 14, 2022
Sleep and Heart Health
Sleep is increasingly recognized as a key to maintaining heart health.
MAY 16, 2022
Technology
An Implantable Vascular Monitoring Device
MAY 16, 2022
An Implantable Vascular Monitoring Device
Vascular diseases are one of the most common causes of death around the globe. Encompassing a range of conditions (such ...
MAY 22, 2022
Drug Discovery & Development
Gout Medication Helps Hospitalized People with Heart Failure
MAY 22, 2022
Gout Medication Helps Hospitalized People with Heart Failure
A research team at the University of Virginia Hospital System found that a regularly-used medication for gout, called co ...
JUN 12, 2022
Neuroscience
Multiple Heart-Related Conditions Triples Dementia Risk
JUN 12, 2022
Multiple Heart-Related Conditions Triples Dementia Risk
People who have multiple cardiometabolic conditions have a three times higher dementia risk than those with a high genet ...
Loading Comments...